DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Kashiwagi A, Takahashi H, Ishikawa H. et al.
A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the long-term ASP1941 safety evaluation in patients with type 2 diabetes with renal impairment (LANTERN) study.
Diabetes Obes Metab 2015;
17: 152-160
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.